Amova Asset Management Americas Inc. Has $22.99 Million Holdings in Corteva, Inc. $CTVA

Amova Asset Management Americas Inc. decreased its stake in Corteva, Inc. (NYSE:CTVA) by 9.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 339,908 shares of the company’s stock after selling 37,287 shares during the period. Amova Asset Management Americas Inc. owned approximately 0.05% of Corteva worth $22,985,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CTVA. Activest Wealth Management grew its position in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares in the last quarter. True Wealth Design LLC lifted its position in Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares during the period. Total Investment Management Inc. acquired a new stake in Corteva during the second quarter worth $27,000. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva in the 2nd quarter valued at $29,000. Finally, Redmont Wealth Advisors LLC bought a new stake in Corteva in the 3rd quarter valued at $29,000. Institutional investors own 81.54% of the company’s stock.

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.14% of the stock is currently owned by corporate insiders.

Corteva Price Performance

CTVA opened at $77.98 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock has a market capitalization of $52.44 billion, a P/E ratio of 49.35, a price-to-earnings-growth ratio of 2.70 and a beta of 0.72. The company’s 50 day simple moving average is $72.63 and its 200-day simple moving average is $68.97. Corteva, Inc. has a one year low of $53.40 and a one year high of $80.90.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the prior year, the business earned $0.32 EPS. The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Wolfe Research raised their price target on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Wells Fargo & Company increased their price objective on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Oppenheimer set a $86.00 target price on shares of Corteva in a research note on Thursday, February 5th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. Finally, Royal Bank Of Canada lifted their price target on shares of Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $82.80.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.